**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 1319-46-6 |Lead, bis[carbonato(2-)]dihydroxytri- | >78 | 215-290-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 20/22 33 61 62
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative
effects. May cause harm to the unborn child. Possible risk of
impaired fertility.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. Ingestion of lead compounds can cause toxic effects in the
blood-forming organs, kidneys and central nervous system.
Inhalation:
May cause respiratory tract irritation. May cause effects similar to
those described for ingestion.
Chronic:
Chronic exposure to lead may result in plumbism which is
characterized by lead line in gum, headache, muscle weakness, mental
changes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Antidote:
The use of d-Penicillamine as a chelating agent should be determined
by qualified medical personnel. The use of Dimercaprol or BAL
(British Anti-Lewisite) as a chelating agent should be determined by
qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Vapors may
be heavier than air. They can spread along the ground and collect
in low or confined areas.
Extinguishing Media:
For small fires, use water spray, dry chemical, carbon dioxide or
chemical foam. Use agent most appropriate to extinguish fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up, then place into a suitable container for disposal. Avoid
generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Avoid contact with
eyes, skin, and clothing. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Keep from contact with oxidizing
materials.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate general or local exhaust ventilation to keep airborne
concentrations below the permissible exposure limits.
Exposure Limits
CAS# 1319-46-6:
United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3
(as Pb)
United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m
TWA (as Pb)
United States OSHA: 50 ??g/m3 TWA (as Pb); 30 ??g/m3 Action Level (
Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorgani
compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3
(dust and fume)
France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le
compounds, as Pb)
Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA (
Pb)
Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA
(dust and smoke, as Pb)
Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as
Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED (
Pb)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not applicable.
Boiling Point: Not available.
Freezing/Melting Point: 400 deg C (dec)
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 400 deg C
Solubility in water: Insoluble in water.
Specific Gravity/Density: Not available.
Molecular Formula: C2H2O8Pb3
Molecular Weight: 775.59
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Strong oxidizers.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, lead/lead oxides.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1319-46-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Lead, bis[carbonato(2-)]dihydroxytri- -
California: carcinogen, initial date 10/1/92 (listed as Lead compounds
NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3288
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3288
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3288
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 61 May cause harm to the unborn child.
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 1319-46-6: No information available.
Canada
CAS# 1319-46-6 is listed on Canada's DSL List.
CAS# 1319-46-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1319-46-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 8/05/1998 Revision #5 Date: 10/05/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Trolox, 97%
| 53188-07-1 |
|
Poly(2,2-Dimethyl-1,3-Propylene Succinate) Approximate M.W. 16.000
| 28776-65-0 |
|
1-Benzyl-2-methylimidazole, 95%(gc)
| 13750-62-4 |
|
2-Phenyl-2-imidazoline, 98+%
| 936-49-2 |
|
Pyridazine, 98+%
| 289-80-5 |
|
Butyraldehyde, P.A. Contains Less Than 1% Butyric Acid
| 123-72-8 |
|
2,3-Dimethoxyphenol, 99%
| 5150-42-5 |
|
4-Octylbenzaldehyde, 99% (GC)
| 49763-66-8 |
|
4-Aminophenethyl alcohol, 97% (gc)
| 104-10-9 |
|
2,6-Dinitrotoluene, 99%
| 606-20-2 |
|
Methanethiol, 99.5+%
| 74-93-1 |
|
Benzanilide 98%
| 93-98-1 |
|
2-Amino-6,8-Dihydroxypurine, Tech., ca.85% (HPLC)
| 5614-64-2 |
|
2-Dimethylaminoethyl Methacrylate, 99% (GC), Stabilized
| 150-76-5 |
|
Butyric Acid, Sodium Salt, 99%
| 156-54-7 |
|
N,n',n",n"'-tetraacetylglycoluril, 98+%
| 10543-60-9 |
|
2-Ethylhexyl Acetate, 99% (GC)
| 103-09-3 |
|
Alpha, Alpha, Alpha-Trifluoro-O-Toluic Acid, 98%
| 433-97-6 |
|
Deuterium Oxide, 99.8 Atom % D
| 7789-20-0 |
|
Phenothiazine-10-carbonyl chloride 98%
| 18956-87-1 |
|
4-Chloro-2-Nitrotoluene, 99%
| 89-59-8 |
|
1,12-Dodecanedicarboxylic Acid, 98%
| 821-38-5 |
|
Lead(II) carbonate, basic, -325 mesh
| 1319-46-6 |
|
4'-Chloro-2'-Fluoroacetanilide , 99+%(TLC)
| 59280-70-5 |
|
2-Benzoylbenzoic acid, 98+%
| 85-52-9 |
|
d-(+)-Galactosamine Hydrochloride, 99%
| 1772-03-8 |
|
2-Benzylpyridine, 98%
| 101-82-6 |
|
Trypan Blue
| 72-57-1 |
|
Ethyl caprylate, 99+%
| 106-32-1 |
|
4-(Hydroxymercury)benzoic acid sodium salt
| 138-85-2 |
|
(2S,3S),(2S,3R)-2-Amino-3-Hydroxy-4-Methyl Pentanoic Acid, 99+% e.e.
| 0-01-1 |
|
Ethylenediamine-N,N'-diacetic acid, 98+%
| 5657-17-0 |
|
2-Acetoxy-3,3-dichlorotetrahydrofuran 98+%
| |
|
2-Nitroaniline, 98%
| 88-74-4 |
|
DL-Homatropine Hydrobromide, 98.5-100.5% (on Dry Subst.)
| 51-56-9 |
|
4-Methyl-3-nitroanisole, 99%
| 17484-36-5 |
|
Chromotrope 2b
| 548-80-1 |
|
3-Hydroxytyramine hydrobromide, 99%
| 51-61-6 |
|
1,4-Bis(2-Hydroxyethoxy)-2-Butyne
| 1606-85-5 |
|
Oxonic acid, potassium salt, 97.5%
| 2207-75-2 |
|
(-)-Chiracamphox
| 165038-32-4 |
|
Iminodiacetonitrile, 98%
| 628-87-5 |
|
Heptanoyl chloride, 99%(titr.)
| 2528-61-2 |
|
Azocarmine G (Cert)
| 25641-18-3 |
|
New Coccine
| 2611-82-7 |
|
(2-Fluorophenyl)(4-methoxy-3-nitrophenyl) methanone, 95%
| |
|
1-Chloropropane, 99%
| 540-54-5 |
|
2-Methylglutaric acid, 99%
| 18069-17-5 |
|
3,4,5-Trimethoxyaniline, 97%
| 24313-88-0 |
|
5-Chloro-2-(trichloromethyl)benzimidazole , 95%
| 3584-66-5 |
|
|